Pfizer Inc. recalls

All Pfizer Inc. recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (7).

7 recalls published between July 2, 2025 and September 23, 2026. Most common issues: sterility (3), manufacturing practices (cgmp) (2), potency (1).

• Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose… recall
  FDA September 23, 2026 · Pfizer Inc. · Class II
• Vial Label: 8.4% Sodium Bicarbonate Injection, USP… recall
  FDA August 27, 2025 · Pfizer Inc. · Class II
• Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only… recall
  FDA August 27, 2025 · Pfizer Inc. · Class II
• Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle… recall
  FDA August 20, 2025 · Pfizer Inc. · Class II
• Bicillin L-A (penicillin G benzathine injectable suspension)… recall
  FDA August 6, 2025 · Pfizer Inc. · Class II
• Bicillin L-A (penicllin G benzathine injectable suspension)… recall
  FDA August 6, 2025 · Pfizer Inc. · Class II
• DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL)… recall
  FDA July 2, 2025 · Pfizer Inc. · Class II